{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T00:49:38Z","timestamp":1789001378624,"version":"build-2803163510"},"reference-count":39,"publisher":"Public Library of Science (PLoS)","issue":"12","license":[{"start":{"date-parts":[[2022,12,7]],"date-time":"2022-12-07T00:00:00Z","timestamp":1670371200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008156","name":"Carolinas HealthCare Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008156","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:p>Breast cancer is heterogenous in development and cell population with prognoses being highly dependent on numerous factors from driving mutations, biomarker expression and variation in extracellular environment, all affecting response to therapies. Recently, much attention has been given to the role of metabolic alteration in cancers, expanding from the Warburg effect to highlight unique patterns in different cancer cell populations for improving diagnostic and therapeutic approaches. We recently reported on modulation of mannosylation of \u03b1-dystroglycan with the metabolite ribitol in breast cancer lines. Here we investigate the effects of pentose sugars ribitol, ribose, and xylitol media supplementation in breast cancer cells by metabolomics and differential gene expression profiling. This combined approach revealed distinctive patterns of alterations in metabolic pathways by ribitol, contrasted with the closely related pentose ribose and pentitol xylitol. Significantly, ribitol supplementation enhances utilization of glucose by glycolysis, whereas ribose improves oxidative phosphorylation and fatty acid synthesis. Ribitol supplementation also increased levels of reduced glutathione (associated with a decrease in oxidative phosphorylation, gluconeogenesis), where ribose supplementation elevated levels of oxidized glutathione (GSSG) indicating an increase in oxidative stress. Treatment with ribitol also enhanced nucleotide biosynthesis. The apparent TCA cycle dysregulation, with distinctive pattern in response to the individual pentitol and pentose, such as ribitol increasing succinate and fumarate while decreasing citrate, demonstrate the adaptive capability of cancer cells to nutritional environment. This metabolic reprogramming presents new avenues for developing targeted therapies to cancers with metabolites, especially in combination with other drug treatments.<\/jats:p>","DOI":"10.1371\/journal.pone.0278711","type":"journal-article","created":{"date-parts":[[2022,12,7]],"date-time":"2022-12-07T18:36:54Z","timestamp":1670438214000},"page":"e0278711","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":19,"title":["Ribitol alters multiple metabolic pathways of central carbon metabolism with enhanced glycolysis: A metabolomics and transcriptomics profiling of breast cancer"],"prefix":"10.1371","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6558-7808","authenticated-orcid":true,"given":"Jason Driver","family":"Tucker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ravi","family":"Doddapaneni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei Juan","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi Long","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2022,12,7]]},"reference":[{"issue":"12","key":"pone.0278711.ref001","doi-asserted-by":"crossref","first-page":"2900","DOI":"10.3390\/cancers13122900","article-title":"Metabolic Rewiring and the Characterization of Oncometabolites","volume":"13","author":"D Beyo\u011flu","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"9","key":"pone.0278711.ref002","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1007\/s13238-015-0185-x","article-title":"Functional metabolomics: from biomarker discovery to metabolome reprogramming","volume":"6","author":"B Peng","year":"2015","journal-title":"Protein Cell"},{"issue":"7","key":"pone.0278711.ref003","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.3390\/molecules22071173","article-title":"Novel Applications of Metabolomics in Personalized Medicine: A Mini-Review","volume":"22","author":"B Li","year":"2017","journal-title":"Molecules"},{"key":"pone.0278711.ref004","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1126\/science.123.3191.309","article-title":"On the origin of cancer cells","volume":"123","author":"O. Warburg","year":"1956","journal-title":"Science"},{"key":"pone.0278711.ref005","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: The next generation","volume":"144","author":"D Hanahan","year":"2011","journal-title":"Cell"},{"issue":"3","key":"pone.0278711.ref006","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.ccr.2012.02.014","article-title":"Metabolic reprogramming: a cancer hallmark even warburg did not anticipate","volume":"21","author":"PS Ward","year":"2012","journal-title":"Cancer Cell"},{"issue":"10","key":"pone.0278711.ref007","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1158\/2159-8290.CD-12-0345","article-title":"Cancer cell metabolism: one hallmark, many faces","volume":"2","author":"JR Cantor","year":"2012","journal-title":"Cancer Discov"},{"issue":"6487","key":"pone.0278711.ref008","doi-asserted-by":"crossref","DOI":"10.1126\/science.aaw5473","article-title":"Metabolic reprogramming and cancer progression","volume":"368","author":"B Faubert","year":"2020","journal-title":"Science"},{"key":"pone.0278711.ref009","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1038\/nrc.2016.100","article-title":"The current state of cancer metabolism","volume":"16","author":"RA Cairns","year":"2016","journal-title":"Nat. Rev. Cancer"},{"issue":"2","key":"pone.0278711.ref010","doi-asserted-by":"crossref","first-page":"89","DOI":"10.3390\/cells8020089","article-title":"Metabolic Reprogramming in Breast Cancer and Its Therapeutic Implications","volume":"8","author":"N Gandhi","year":"2019","journal-title":"Cells"},{"issue":"1","key":"pone.0278711.ref011","doi-asserted-by":"crossref","first-page":"4935","DOI":"10.1038\/s41598-020-61747-z","article-title":"Ribitol enhances matriglycan of alpha-dystroglycan in breast cancer cells without affecting cell growth","volume":"10","author":"PJ Lu","year":"2020","journal-title":"Sci Rep"},{"issue":"42","key":"pone.0278711.ref012","doi-asserted-by":"crossref","first-page":"17426","DOI":"10.1073\/pnas.1114836108","article-title":"Like-acetylglucosaminyltransferase (LARGE)-dependent modification of dystroglycan at Thr-317\/319 is required for laminin binding and arenavirus infection","volume":"108","author":"Y Hara","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"7","key":"pone.0278711.ref013","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1093\/glycob\/cwv021","article-title":"Matriglycan: a novel polysaccharide that links dystroglycan to the basement membrane","volume":"25","author":"T Yoshida-Moriguchi","year":"2015","journal-title":"Glycobiology"},{"issue":"3","key":"pone.0278711.ref014","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/S0002-9440(10)63881-3","article-title":"Dystroglycan expression is frequently reduced in human breast and colon cancers and is associated with tumor progression","volume":"162","author":"A Sgambato","year":"2003","journal-title":"Am. J. Pathol"},{"issue":"8","key":"pone.0278711.ref015","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1053\/hupa.2001.26468","article-title":"Reduced expression of dystroglycan in breast and prostate cancer","volume":"32","author":"MD Henry","year":"2001","journal-title":"Hum. Pathol"},{"issue":"23","key":"pone.0278711.ref016","first-page":"7102","article-title":"A role for dystroglycan in epithelial polarization: loss of function in breast tumor cells","volume":"62","author":"J Muschler","year":"2002","journal-title":"Cancer Res"},{"issue":"4","key":"pone.0278711.ref017","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.1074\/jbc.M112.432807","article-title":"Loss of LARGE2 disrupts functional glycosylation of \u03b1-dystroglycan in prostate cancer","volume":"288","author":"A Esser","year":"2013","journal-title":"J Biol Chem"},{"issue":"17","key":"pone.0278711.ref018","doi-asserted-by":"crossref","first-page":"6152","DOI":"10.1158\/0008-5472.CAN-04-1638","article-title":"Proteolytic enzymes and altered glycosylation modulate dystroglycan function in carcinoma cells","volume":"64","author":"J Singh","year":"2004","journal-title":"Cancer Res"},{"key":"pone.0278711.ref019","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/1756-9966-31-71","article-title":"Increased expression of CD133 and reduced dystroglycan expression are strong predictors of poor outcome in colon cancer patients","volume":"31","author":"C Coco","year":"2012","journal-title":"J Exp Clin Cancer Res"},{"issue":"12","key":"pone.0278711.ref020","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.4161\/cbt.6.12.4983","article-title":"Expression of dystroglycan correlates with tumor grade and predicts survival in renal cell carcinoma","volume":"6","author":"A Sgambato","year":"2007","journal-title":"Cancer Biol. Ther"},{"issue":"17","key":"pone.0278711.ref021","doi-asserted-by":"crossref","first-page":"11279","DOI":"10.1074\/jbc.C900007200","article-title":"Loss of alpha-dystroglycan laminin binding in epithelium-derived cancers is caused by silencing of LARGE","volume":"284","author":"D de Bernabe","year":"2009","journal-title":"J. Bio.l Chem"},{"issue":"6","key":"pone.0278711.ref022","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1016\/j.joms.2013.12.031","article-title":"Correlation of deregulated like-acetylglucosaminyl transferase and aberrant alpha-dystroglycan expression with human tongue cancer metastasis","volume":"72","author":"HZ Zhang","year":"2014","journal-title":"J. Oral Maxillofac. Surg"},{"key":"pone.0278711.ref023","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.omtm.2019.12.005","article-title":"ISPD Overexpression Enhances Ribitol-Induced Glycosylation of alpha-Dystroglycan in Dystrophic FKRP Mutant Mice","volume":"17","author":"M Cataldi","year":"2019","journal-title":"Mol Ther Methods Clin Dev"},{"key":"pone.0278711.ref024","doi-asserted-by":"crossref","first-page":"6656","DOI":"10.1021\/ac901536h","article-title":"Integrated, nontargeted ultrahigh performance liquid chromatography\/electrospray ionization tandem mass spectrometry platform for the identification and relative quantification of the small-molecule complement of biological systems","volume":"81","author":"A. M. Evans","year":"2009","journal-title":"Anal. Chem"},{"key":"pone.0278711.ref025","doi-asserted-by":"crossref","first-page":"9440","DOI":"10.1073\/pnas.1530509100","article-title":"Statistical significance for genomewide studies","volume":"100","author":"J. D. Storey","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"3","key":"pone.0278711.ref026","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.tibs.2015.12.001","article-title":"The Warburg Effect: How Does it Benefit Cancer Cells?","volume":"41","author":"M Liberti","year":"2016","journal-title":"Trends Biochem Sci"},{"issue":"41","key":"pone.0278711.ref027","first-page":"38023","article-title":"Effect of insulin on cell cycle progression in MCF-7 breast cancer cells","volume":"276","author":"J Chappell","year":"2001","journal-title":"Direct and potentiating influence J Biol Chem"},{"issue":"10","key":"pone.0278711.ref028","doi-asserted-by":"crossref","first-page":"4296","DOI":"10.1073\/pnas.74.10.4296","article-title":"New pathway for the metabolism of pentitols","volume":"74","author":"J London","year":"1977","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"pone.0278711.ref029","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.ymgme.2004.05.003","article-title":"Evaluation of pentitol metabolism in mammalian tissues provides new insight into disorders of human sugar metabolism","volume":"82","author":"J Huck","year":"2004","journal-title":"Mol Genet Metab"},{"issue":"1","key":"pone.0278711.ref030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7575\/aiac.abcmed.v.6n.1p.1","article-title":"Understanding D-Ribose and Mitochondrial Function","volume":"6","author":"D Mahoney","year":"2018","journal-title":"Adv Biosci Clin Med"},{"issue":"3","key":"pone.0278711.ref031","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.3390\/cancers6031769","article-title":"Drug Resistance in Cancer: An Overview","volume":"6","author":"S Byler","year":"2014","journal-title":"Cancers (Basel)"},{"key":"pone.0278711.ref032","article-title":"Drug resistance and combating drug resistance in cancer","author":"X Wang","year":"2021","journal-title":"Cancer Drug Resist"},{"key":"pone.0278711.ref033","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1038\/nrc3599","article-title":"Cancer drug resistance: an evolving paradigm","volume":"13","author":"C Holohan","year":"2013","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"pone.0278711.ref034","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1038\/s41572-019-0111-2","article-title":"Breast cancer","volume":"5","author":"N Harbeck","year":"2019","journal-title":"Nat Rev Dis Primers"},{"key":"pone.0278711.ref035","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.ijdevneu.2014.06.009","article-title":"Polyols accumulated in ribose-5-phosphate isomerase deficiency increase mitochondrial superoxide production and improve antioxidant defenses in rats\u2019 prefrontal cortex","volume":"37","author":"V Stone","year":"2014","journal-title":"Int J Dev Neurosci"},{"issue":"4","key":"pone.0278711.ref036","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1086\/383204","article-title":"Ribose-5-Phosphate Isomerase Deficiency: New Inborn Error in the Pentose Phosphate Pathway Associated with a Slowly Progressive Leukoencephalopathy","volume":"74","author":"J Huck","year":"2004","journal-title":"Am J Hum Genet"},{"issue":"7","key":"pone.0278711.ref037","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.3390\/ijms20071647","article-title":"AICAR Induces Apoptosis and Inhibits Migration and Invasion in Prostate Cancer Cells Through an AMPK\/mTOR-Dependent Pathway","volume":"20","author":"C Su","year":"2019","journal-title":"Int J Mol Sci"},{"issue":"1","key":"pone.0278711.ref038","doi-asserted-by":"crossref","first-page":"224","DOI":"10.3892\/ol.2011.458","article-title":"Effects of activation of AMPK on human breast cancer cell lines with different genetic backgrounds","volume":"3","author":"O El-Masry","year":"2012","journal-title":"Oncol Lett"},{"issue":"2","key":"pone.0278711.ref039","doi-asserted-by":"crossref","first-page":"e0150232","DOI":"10.1371\/journal.pone.0150232","article-title":"Combined Treatment of MCF-7 Cells with AICAR and Methotrexate, Arrests Cell Cycle and Reverses Warburg Metabolism through AMP-Activated Protein Kinase (AMPK) and FOXO1","volume":"11","author":"T. Fodor","year":"2016","journal-title":"PLoS One"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0278711","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,7]],"date-time":"2022-12-07T18:37:21Z","timestamp":1670438241000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0278711"}},"subtitle":[],"editor":[{"given":"Pankaj K","family":"Singh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2022,12,7]]},"references-count":39,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2022,12,7]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0278711","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,7]]}}}